Xcout Intel
Provention Bio, Inc.
Provention Bio, Inc. is a clinical-stage biopharmaceutical company based in Red Bank, New Jersey, focused on advancing transformational investigational therapies for the prevention and immune-mediated disease treatment.
Subscribe to see Provention Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Provention Bio, Inc. at a glance
Provention Bio, Inc. is a company headquartered in United States. Its most recent funding round raised $28.5M in April 2017. Xcout tracks 8 named people at Provention Bio, Inc., including Colleen Proctor (CFO North America).
Provention Bio, Inc. leadership
- Colleen ProctorCFO North America
- Kimberly TutwilerHead of Vaccines, North America
- Michael HulkaGeneral Counsel North America and Head of Legal Specialty Care GBU
- Rakesh KakkarHead of Manufacturing & Supply, Vaccines, US
- Chisom ObioraNorth America People & Culture Director
- Adam GluckHead U.S. and Specialty Care Corporate Affairs
2 more named people on record for Provention Bio, Inc., with roles, board committees and tenure — see the full roster →
Provention Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $28.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Provention Bio, Inc. competitors
A few of Provention Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Diamyd Medical develops precision medicine therapies focused on the prevention and treatment of type 1 diabetes. The company's primary product is retogatein (rhGAD65), an investigational antigen-specific immunotherapy currently undergoing late-stage clinical trials.
Providence Therapeutics Inc. is a clinical-stage biotechnology company focused on developing mRNA-based vaccines and therapeutics. The company utilizes its proprietary technology platform to advance drug pipelines and clinical trials.
Praeventix, Inc. is an early development stage biopharmaceutical company based in Exton, Pennsylvania, focused on the discovery, research, and early clinical development of novel products.
Protalex, Inc. is a biopharmaceutical company incorporated in 2014 and based in San Antonio, Texas, focused on the development of novel immunotherapeutic drugs for autoimmune diseases.
Pandion Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Cambridge and Watertown, Massachusetts. The company focuses on developing novel therapeutics to modulate the immune system for autoimmune and inflammatory diseases.
ProThera Biologics, Inc. is a biotherapeutics company developing inter-alpha inhibitor proteins for various clinical applications, with its corporate office located in Providence, Rhode Island.
Get Provention Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Provention Bio, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access